Appetite for cheaper biologics spreads across the map

On October 22, Epirus Biopharmaceuticals of Boston signed a biosimilars deal with São Paulo’s Orygen Biotecnologica in Brazil. The previous month, Redwood City, California– based Coherus and Deerfield, Illinois–based Baxter International partnered to develop biosimilar etanercept in Europe, Canada, Brazil and “certain other” markets. Earlier in May… (More)